# Health outcomes and cost effectiveness analysis of Psosol vs placebo for patients with Psoriasis
Psosol is a new topical ointment which has been developed for the treatment of Psoriasis. 
A pragmatical trial was carried out amongst 455 study participants with Psoriasis to investigate the effects of Psosol versus Placebo in this patient population. Outcomes of interest included severity of Psoriasis measured with the PASI, health utility measured with EQ-5D-3L tool. Other outcomes measured included health utilizaton like doctor visits and work impairment.
The Qol_Pso and PsoProve_RCT files contain the data from this trial study.
This analysis included data exploration, Quality adjusted life year calculation, costing analysis and cost utility analysis.
